A registry-based observational study assessing clinical outcomes in familial adenomatous polyposis in patients receiving celecoxib (Celebrex, Onsenal) compared with control patients.
Phase of Trial: Phase IV
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Celecoxib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 09 Mar 2010 Actual Patient numbers amended from 72 to 68 as reported by ClinicalTrials.gov.
- 15 Sep 2008 Actual patient number (72) added as reported by ClinicalTrials.gov.
- 15 Sep 2008 Planned end date added (1 May 2008) as reported by ClinicalTrials.gov.